Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Lenehan

Orthopaedic Surgery of the Spine Greenville, SC Medical Doctor

NPI 1265697536 CMS profile 103199

111 Doctors Dr, Greenville, SC 29605

Open in the dashboard

General payments

$49,745

149 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Lenehan of Greenville, SC is reported in the CMS Open Payments database as having received $49,745 across 149 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,641 39
2024 General $1,673 17
2023 General $729 14
2022 General $14,755 35
2021 General $2,737 26
2020 General $47 2
2019 General $13,163 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Lenehan
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Eric Lenehan were reported at $16,641. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Eric Lenehan Orthopaedic Surgery of the Spine median Middle half National median
2019 $13,163 $2,106 $337–$18,608 $163
2020 $47 $1,213 $156–$15,082 $114
2021 $2,737 $1,834 $271–$15,617 $132
2022 $14,755 $2,015 $320–$17,036 $149
2023 $729 $1,925 $336–$14,599 $160
2024 $1,673 $2,110 $341–$12,483 $164
2025 $16,641 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $39,014 59 payments
  2. Alphatec Spine, Inc $3,944 10 payments
  3. NuVasive, Inc. $2,796 27 payments
  4. Medical Device Business Services, Inc. $989 5 payments
  5. Abbott Laboratories $874 20 payments
  6. Peerless Surgical Inc. $685 3 payments
  7. DePuy Synthes Sales Inc. $625 8 payments
  8. Arthrex, Inc. $366 5 payments
  9. Stryker Corporation $139 1 payment
  10. Medtronic, Inc. $116 4 payments
  11. Other $197 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $21,400 11 payments
  2. Travel and Lodging $14,496 44 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,400 2 payments
  4. Food and Beverage $5,450 92 payments
Products named General payments · program years 2019–2025
  1. MARS TLIF Retractor $11,424 7 payments
  2. EXCELSIUS GPS $11,130 13 payments
  3. CALIBER $9,083 3 payments
  4. Other - Miscellaneous $3,341 7 payments
  5. XLIF $1,351 14 payments
  6. RISE-L $1,341 2 payments
  7. ELSA ATP $1,206 2 payments
  8. MARS 3VL $1,063 2 payments
  9. Velys $989 5 payments
  10. Pulse $896 5 payments
  11. Other $6,204 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

117

Median for Orthopedic Surgery: 203

Drug cost

$647

Median for Orthopedic Surgery: $1,433

Branded share of claims

9.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 37 $205
Pregabalin Generic 13 $148
Oxycodone Hcl Generic 14 $103
Methylprednisolone Generic 13 $63
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $56
Tramadol Hcl Generic 12 $36
Cyclobenzaprine Hcl Generic 17 $35

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$247,371

Medicare's payments for the services billed

Medicare patients

338

Average age 74

Services billed

984

190 women, 148 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 30%
Depression 29%
Diabetes 28%
Chronic kidney disease 27%
Cancer 21%
Osteoporosis 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

149 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record